Polyphor's Stock Slides As Murepavadin Trials Are Halted

 
• By Kevin Grogan
  
Stock market
Polyphor stock stumbles in Switzerland • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas